EUDA Health Holdings Ltd
NASDAQ:EUDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
EUDA Health Holdings Ltd
NASDAQ:EUDA
|
SG |
|
Emerald Resources NL
ASX:EMR
|
AU |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
US |
|
S
|
Shalag Industries Ltd
TASE:SALG
|
IL |
|
Indoco Remedies Ltd
NSE:INDOCO
|
IN |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
BNP Paribas Bank Polska SA
F:82MA
|
PL |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
OSB Group PLC
LSE:OSB
|
UK |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
M
|
Meritor Inc
F:AID1
|
US |
Wall Street
Price Targets
EUDA Price Targets Summary
EUDA Health Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
EUDA
is 56.1 USD
with a low forecast of 55.55 USD and a high forecast of 57.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EUDA's stock price target?
Price Target
56.1
USD
According to Wall Street analysts, the average 1-year price target for
EUDA
is 56.1 USD
with a low forecast of 55.55 USD and a high forecast of 57.75 USD.
What is EUDA Health Holdings Ltd's Revenue forecast?
Projected CAGR
163%
For the last 1 year the
compound annual growth rate for
EUDA Health Holdings Ltd's revenue is
8%.
The projected
CAGR
for the next 2 years is
163%.